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Mutations in Mucolipin 1 (MCOLN1) have been linked to mucolipidosis type IV (MLIV), a lysosomal storage
disease characterized by several neurological and ophthalmological abnormalities. It has been proposed
that MCOLN1 might regulate transport of membrane components in the late endosomal–lysosomal pathway;
however, the mechanisms by which defects of MCOLN1 function result in mental and psychomotor retar-
dation remain largely unknown. In this study, we show constitutive activation of autophagy in ﬁbroblasts
obtained from MLIV patients. Accumulation of autophagosomes in MLIV cells was due to the increased de
novo autophagosome formation and to delayed fusion of autophagosomes with late endosomes/lysosomes.
Impairment of the autophagic pathway led to increased levels and aggregation of p62, suggesting that abnor-
mal accumulation of ubiquitin proteins may contribute to the neurodegeneration observed in MLIV patients.
In addition, we found that delivery of platelet-derived growth factor receptor to lysosomes is delayed in
MCOLN1-deﬁcient cells, suggesting that MCOLN1 is necessary for efﬁcient fusion of both autophagosomes
and late endosomes with lysosomes. Our data are in agreement with recent evidence showing that auto-
phagic defects may be a common characteristic of many neurodegenerative disorders.
INTRODUCTION
Autophagy (or more speciﬁcally macroautophagy) is a process
that mediates sequestration of macromolecules and organelles
into specialized cytosolic vesicles for subsequent delivery and
degradation in lysosomes (1–3). Activation of autophagy
occurs when cells undergo stress conditions, such as star-
vation, accumulation of damaged organelles or oxidative
stress, and serves two main purposes: the production of nutri-
ents and the elimination of products potentially toxic for the
cell (4). Recently, it has been suggested that autophagy may
also play a very important role in cell homeostasis during
non-stress conditions, as the basal activity of the autophagic
process is required for the degradation of misfolded proteins
and organelle turnover. Basal autophagy may be especially
important in neurons, where accumulation of aggregated pro-
teins often results in cell death (5). Accordingly, transgenic
mice that lack speciﬁc components of the autophagic machin-
ery exhibit accumulation of ubiquitin-rich inclusions in
neurons and progressive neurodegeneration (6,7). Moreover,
accumulation of autophagic vacuoles has been described
in several neurodegenerative disorders in humans, including
Parkinson’s (8,9), Alzheimer’s (10,11) and Huntington’s
disease (12).
The autophagic machinery is highly conserved among
eukaryotes. In yeast, over 30 autophagy-related (Atg) pro-
teins have been identiﬁed (13). Most of these proteins
mediate protein–protein and protein–lipid conjugation
events, although some others, such as phosphoinositide
3-kinase (PI3K) class III and beclin-1, have an important
regulatory role. The process starts with the sequestration of
a portion of the cytoplasm by a double membrane structure
that grows and seals to form an autophagosome. LC3, the
mammalian homolog of yeast Atg8, is one of the most
selective markers for autophagosomes. Cleavage and sub-
sequent attachment of a phosphatidylethanolamine (PE)
group (14) allows insertion of LC3 into the membrane of
the autophagosome. It is widely accepted that increased
levels of PE-conjugated LC3 correlates with increased
autophagy (15).
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including endosomal multivesicular bodies (MVB) and lyso-
somes. This fusion ensures degradation of the autophagosome
content by lysosomal enzymes. Recent evidence suggests
that alterations on the endosomal–lysosomal pathway that
impair autophagosome degradation may also play a role
in a number of neurodegenerative disorders. For example,
mutations in CHMP2B, a component of the ESCRT machinery
that mediates sorting of proteins into the luminal vesicles of
MVBs, have been described in patients with amyotrophic
lateral sclerosis (16) and a rare form of fronto-temporal
dementia (17); while spastin, a protein mutated in many
cases of hereditary spastic paraplegia, is known to interact
with CHMP1B (18). In addition, depletion of speciﬁc subunits
of the ESCRT complex by siRNA results in increased autop-
hagy and accumulation of protein aggregates containing
ubiquitinated proteins (19). Therefore, efﬁcient autophagy
requires fusion with a functional endosomal–lysosomal
pathway, and defects in autophagy degradation cause accumu-
lation of ubiquitinated protein inclusions that may lead to
neurodegeneration (20).
Mucolipidosis type IV (MLIV) is a lysosomal storage
disorder (LSD) characterized by severe neurological and
ophthalmological abnormalities due to defective transport of
membrane components in the late endosomal–lysosomal
pathway. Individuals with MLIV suffer from mental and psy-
chomotor retardation, severe neurodegeneration, diminished
muscle tone or hypotonia, achlorhydria and visual problems
including corneal clouding, retinal degeneration, sensitivity
to light and strabismus (21–23). Mucolipin-1 (MCOLN1),
the protein mutated in this disease, is a cation channel with
homology to the transient receptor potential channel super-
family (24–27). MCOLN1 consists of six transmembrane-
spanning domains with the N- and C-terminal tails oriented
within the cytosol and the pore located between trans-
membrane segments 5 and 6. Two acidic di-leucine sorting
motifs are responsible for the transport of the protein to late
endosomes/lysosomes (28–30). MCOLN1 is a non-selective
channel with preference for monovalent cations (31–34) and
its activity can be modulated by phosphorylation (35) and by
changes in pH and Ca
2þ concentration (32,33,36).
Analysis of ﬁbroblasts obtained from MLIV patients
revealed the accumulation of enlarged vacuoles that contain
sphingolipids, phospholipids and acid mucopolysaccharides
(24,37–39), suggesting that MCOLN1 might be necessary
for the correct trafﬁcking of protein and lipids along the late
endosomal/lysosomal pathway. This idea is supported by
experiments in Caenorhabditis elegans showing that knockout
of cup-5, the ortholog of MCOLN1, resulted in the formation
of enlarged hybrid organelles that contain both late-endosomal
and lysosomal markers (40). Recently, several groups have
suggested additional roles for MCOLN1 in different cellular
processes, including regulation of lysosomal acidiﬁcation
(36), mitochondria turnover (41) and lysosomal secretion
(42). However, the mechanism by which defects on
MCOLN1 function result on mental and psychomotor retar-
dation remains largely unknown.
In this study, we examined the autophagic process in ﬁbro-
blasts from MLIV patients. We reasoned that the defects
on the late endosomal/lysosomal pathway observed in
MLIV might have a profound impact on the formation and/
or degradation of autophagosomes. As predicted, we found
that absence of MCOLN1 resulted in increased basal auto-
phagy and decreased autophagosome degradation. In normal
conditions, MLIV ﬁbroblasts accumulate many more
LC3-positive structures than control ﬁbroblasts. Almost all
the LC3-positive structures also contain p62, suggesting an
abnormal accumulation of ubiquitinated proteins in patients.
After autophagy induction by starvation, fusion of autophago-
somes with late endosomes–lysosomes was less efﬁcient in
MLIV ﬁbroblasts. We also observed delayed delivery of
PDGFR to lysosomes in MCOLN1-deﬁcient cells. Therefore,
MCOLN1 seems to regulate trafﬁcking events along the late
endosomal–lysosomal pathway and we propose that defects
on these trafﬁcking events result in inefﬁcient autophagy and
accumulation of ubiquitinated proteins that may contribute
to neurodegenerative process observed in MLIV patients.
RESULTS
Monitoring autophagy in human ﬁbroblasts
LC3 is the most commonly used marker to monitor autophagy
in mammalian cells. Under normal conditions, LC3 shows
a cytosolic distribution; however, following authophagy
induction, it is recruited to newly formed autophagosomes
and remains associated to these structures until fusion of
autophagosomes with late endosomes/lysosomes. As seen in
Figure 1A, starvation of ﬁbroblasts by incubation with
Earle’s balanced salt solution (EBSS) for 3 h caused an
evident recruitment of LC3 to discrete vesicular structures.
Subsequent incubation with complete media for one additional
hour (recovery) allowed autophagosome degradation and
redistribution of LC3 to cytosol. Therefore, monitoring
changes in the distribution of endogenous LC3 is a suitable
way to follow autophagy in human ﬁbroblasts.
Basal levels of autophagy are increased in MLIV
ﬁbroblasts
To assess whether the autophagic process is altered in MLIV,
we compared the distribution of endogenous LC3 in normal
non-starvation conditions between control ﬁbroblasts and
ﬁbroblasts obtained from MLIV patients. As expected, LC3
was mainly cytosolic in untreated control cells, although
occasional LC3-labeled autophagosomes could also be
detected (Fig. 1B). In contrast, numerous LC3-positive struc-
tures were observed in MLIV ﬁbroblasts, suggesting a consti-
tutive activation of basal autophagy in these cells (Fig. 1B).
Quantiﬁcation analysis revealed that the average number of
autophagosomes in control cells was 12.8 (SD+1.3, n ¼
10), whereas in MLIV cells, the average number of auto-
phagosomes increased to 54.2 (SD+3.2, n ¼ 10).
We labeled MLIV cells with antibodies against LC3 and
CD63, a marker for late endosomes/lysosomes. As seen in
Figure 1C, some LC3-positive vesicles did not co-localize
with CD63. These vesicles were probably nascent autophago-
somes, because they were free from any lysosomal chara-
cteristics. We also observed many LC3-labeled puncta that
2724 Human Molecular Genetics, 2008, Vol. 17, No. 17Figure 1. Increased autophagy in ﬁbroblasts from MLIV patients. (A) Control ﬁbroblasts grown in complete media (untreated, left), starved in EBSS media for
3 h (starvation, center) or starved for 3 h followed by 1 h of recovery in complete media (recovery, right), were ﬁxed, permeabilized and immunostained with a
polyclonal antibody to endogenous LC3. (B) LC3 staining in untreated control and MLIV ﬁbroblasts. Note that in contrast to a diffuse staining in control ﬁbro-
blasts, LC3 shows a vesicular staining in MLIV ﬁbroblasts. (C) MLIV ﬁbroblasts grown in complete media were ﬁxed, permeabilized and immunostained with a
polyclonal antibody to LC3 (red) and a monoclonal antibody against CD63 or p62 (green). Insets show a 3-fold magniﬁcation of the indicated region (D) Double
immunostaining of untreated MLIV cells with anti-LC3 (green) and anti-ubiquitin (red). Cells were examined by confocal ﬂuorescence microscopy. Merging the
images in the red and green channels generated the third picture on each row; yellow indicates overlapping localization. Scale bars ¼ 10 mm.
Human Molecular Genetics, 2008, Vol. 17, No. 17 2725co-localized with CD63, indicating fusion of autophagosomes
with late endosomes/lysosomes.
Interestingly, most of the LC3-positive vesicles also con-
tained p62 (Fig. 1C), a molecule commonly found in protein
inclusions associated with neurodegenerative disorders (43).
It has been suggested that the ability of p62 to interact with
ubiquitinated proteins and LC3 (44) regulates the formation
of protein aggregates that are removed by autophagy (20). In
agreement with this idea, we found that many of the auto-
phagosomes present in MLIV patient cells held ubiquitinated
proteins (Fig. 1D). These results suggest that altered autophagy
observed in MCOLN1-deﬁcient cells results in accumulation of
protein aggregates containing ubiquitinated proteins.
LC3 is initially synthesized in an unprocessed form that is
rapidly cleaved in its C-terminal region to generate soluble
LC3-I. During autophagy induction, the LC3-I isoform is
converted into LC3-II by conjugation of a PE group that
allows insertion of LC3 into the membrane of the auto-
phagosome. It is well established that the amount of LC3-II
correlates with the extent of autophagosome formation. To
Figure 2. Autophagy is upregulated in MLIV ﬁbroblasts. (A) Control and MLIV ﬁbroblasts were treated without or with 50 mg/ml leupeptin for 7 h. Cells were
lysed and immunoblotted with anti-LC3 (top) or anti-actin (bottom). (B) Quantiﬁcation of the experiment shown in (A). Autophagy was measured as the ratio of
LC3-II/LC3-I and is represented as a fold increase of the ratio from control cells without treatment. Results are means+SD (n ¼ 7), P , 0.01. (C) Lysates from
control ﬁbroblasts and MLIV ﬁbroblasts were examined by western blot for expression of beclin-1 and actin. (D) Quantiﬁcation of the levels of beclin-1 normal-
ized with actin is shown as a fold increase of control cells. Results are means+SD (n ¼ 9), P , 0.05. (E) Western blot showing the accumulation of p62 in the
soluble and insoluble fractions of MLIV ﬁbroblasts. (F) Quantiﬁcation was performed by normalizing p62 with actin levels. Results are means+SD (n ¼ 4).
Soluble P , 0.001; insoluble P , 0.05.
2726 Human Molecular Genetics, 2008, Vol. 17, No. 17corroborate that basal autophagy is increased in MLIV, we
analyzed the ratio between LC3-II and LC3-I in control and
patient cells by immunoblot. As seen in Figure 2A, increased
levels of LC3-II were detected in MLIV ﬁbroblasts under
basal conditions. Quantiﬁcation of seven independent exper-
iments showed a 3-fold increase (2.97; SD+0.3) in the
LC3-II/LC3-I ratio in MCOLN1-deﬁcient cells (Fig. 2B). It
has been suggested that in some cases measurement of the
LC3-II/actin ratio may be a more accurate way to monitor
autophagy induction. Quantiﬁcation of the LC3-II/actin
ratio showed a 3.29-fold increase (SD+0.6; n ¼ 7) in
MLIV cells, thus conﬁrming autophagy activation in patients
(Supplementary Material, Fig. S1).
Increased autophagy may be due to either increased autop-
hagosome formation or to decreased autophagosome degra-
dation. To distinguish between these two possibilities, we
incubated cells with leupeptin, an inhibitor of lysosomal pro-
teases. If treatment with leupeptin does not cause an increase
in the LC3-II levels, it is likely that autophagosome accumu-
lation occurred due to inhibition of autophagic degradation.
As seen in Figure 2A and B, the levels of LC3-II did increased
in the presence of leupeptin both in control and patient cells.
These results suggest that fusion of autophagosomes with
lysosomes is not blocked in MLIV cells and that increased
autophagy may be at least partially due to augmented auto-
phagosome formation. However, it is important to note that
leupeptin experiments do not rule out the possibility that
autophagosome degradation is slower in MLIV cells (see
below). Interestingly, expression of beclin-1, a component of
the Class III PI3K complex that participates in autophagosome
formation (45) was increased in MLIV ﬁbroblasts (Fig. 2C
and D). This upregulation of beclin-1 in response to
MCOLN1 deﬁciency could explain the increased autophago-
some formation in patient cells.
We also detected increased levels of p62 in immunoblots of
cells lysates from MLIV ﬁbroblasts (Fig. 2E and F). Impor-
tantly, we found over a 2-fold increase in the amount of inso-
luble p62 in patients (Fig. 2E and F). The fraction of protein
that remains resistant to Triton X-100 extraction is often
used as a quantitative measure of protein aggregation (46).
Therefore, these data are in agreement with our immunoﬂuor-
escence experiments and further demonstrate the accumulation
of p62-positive inclusions in MLIV patient cells. Increased
levels of LC3-II and insoluble p62 were also found in ﬁbro-
blasts obtained from a different MLIV patient (see Materials
and Methods), thus corroborating our results (Supplementary
Material, Fig. S2).
Finally, high levels of basal autophagy in MLIV ﬁbroblasts
were conﬁrmed by transmission electron microscopy (Fig. 3).
This analysis showed frequent autophagic vacuoles containing
organelles and other cytoplasmic contents in mutant, but not in
wild-type ﬁbroblasts (Fig. 3A–E). In addition, we observed
the characteristic concentric multi-lamellar structures and the
electron-dense inclusions previously described in MLIV cells
(Fig. 3F and G) (47). Vesicles containing lamellar structures
and what seems to be semi-degraded material were also
found (Fig. 3H) and might be the result of fusion between
autophagosomes and multi-lamellar vesicles. Altogether, our
results indicate constitutive enhancement of the autophagic
ﬂux in MCOLN1-depleted cells.
Starvation-induced autophagy does not require MCOLN1
Next, we compared autophagy induction under stress con-
ditions in control and mutant ﬁbroblasts. Cells were incubated
for 3 h in medium without amino acids (EBSS) to induce
autophagy. As seen in Figure 4A, nutrient deprivation
caused an increase in the number and size of LC3-positive
vesicles. The average number of autophagosomes per cell
under starvation conditions was 38.9 (SD+6.4, n ¼ 12) in
control ﬁbroblasts and 79.88 (SD+9.31; n ¼ 10) in MLIV
ﬁbroblasts.
Measurement of LC3-II/LC3-I ratio immunobloting con-
ﬁrmed robust autophagy induction in both control and
mutant cells after starvation (Fig. 4B). Quantiﬁcation of four
independent experiments showed a 4.54-fold increase (SD+
0.76) in the LC3-II/LC3-I ratio after starvation in control
cells and a 5.76-fold increase (SD+1.08) in MCOLN1-
deﬁcient cells (Fig. 4C). Similar results were obtained when
the LC3-II/actin ratio was measured (Supplementary Material,
Fig. S1).
Treatment of starved cells with leupeptin resulted in a
further increase of the LC3-II levels in both cell types, consist-
ent with the notion that fusion of autophagosomes and lyso-
somes is not blocked in MLIV cells (Fig. 4B and C).
Moreover, when the cells were let to recover in complete
medium for 1 h after starvation, the LC3-II/LC3-I ratio was
reduced close to the level observed in untreated cells
(Fig. 4B and C). Therefore, these results indicate that
starvation-induced autophagy and autophagosome degradation
can occur in the absence of MCOLN1.
Fusion of autophagosomes with the late endosomal/
lysosomal pathway is delayed in MLIV ﬁbroblasts
As mentioned before, the increased level of LC3-II observed
after treatment with leupeptin indicates that fusion of autopha-
gosomes with late endosomes/lysosomes is not blocked in
MLIV ﬁbroblasts (Figs 2B and 4B). However, these experi-
ments could not disprove that the fusion was delayed at
some extent in mutant cells. To test this possibility, we
starved cells for 3 h in EBSS media followed by short recov-
ery times of 20 and 40 min. As seen in Figure 5A, the number
of LC3-positive vesicles was considerably higher in
MCOLN1-deﬁcient cells when compared with control cells.
Quantiﬁcation of the total number of autophagosomes per
cell revealed that after 20 min recovery only 24.3% of
control cells showed more than 20 autophagosomes and
24.3% had less than 10 (n ¼ 37). In contrast, 62% of
MCOLN1-deﬁcient cells contained more than 20 autophago-
somes and only 1% had less than 10 (n ¼ 24) (Fig. 5B).
After a 40 min recovery, there was an increase in the
percent of MCOLN1-deﬁcient cells containing less than 10
autophagosomes (from 1% at 20 min recovery to 15% at
40 min) and a decrease in the percent of cells showing more
than 20 (from 62–35%) corroborating one more time that
degradation of autophagosomes is not blocked in MLIV ﬁbro-
blasts. However, the number of cells containing more than 20
autophagosomes after a 40 min recovery was signiﬁcantly
greater in mutant cells [32% in mutant cells (n ¼ 20) versus
0% in control cells (n ¼ 44)], whereas the percent of cells
Human Molecular Genetics, 2008, Vol. 17, No. 17 2727showing less than 10 autophagosomes was higher in control
cells (95.45% in control cells versus 15% in mutant cells)
(Fig. 5B). Similar results were obtained when we analyzed
the number of autophagosomes after 20 and 40 min recovery
in a different patient cell line (Supplementary Material,
Fig. S3). Therefore, our data indicate that autophagosome
degradation is in fact delayed in MLIV cells.
When we analyzed co-localization between CD63 and LC3
as a sign of fusion between autophagosomes and late
endosomes/lysosomes, we found that in MLIV patient cells
68.8% (SD+11) of the LC3-positive vesicles co-localize
with CD63 after 20 min recovery, and this percentage
increased to 87.7% (SD+7) after 40 min (Fig. 6). However,
the extent of LC3/CD63 co-localization was signiﬁcantly
Figure 3. Accumulation ofautophagosomes inMLIVﬁbroblasts.Electron micrographsof controlﬁbroblasts (A)and MLIVﬁbroblasts(B). Notethe accumulation
of electron-dense lysosomes and autophagosomes [arrow indicates example similar to that shown in (E)] present in MLIV cells. Scale bars ¼ 2 mm. (C–E).
High magniﬁcation images of membrane-bound structures with cytoplasmic contents, consistent with autophagosomes, in MLIV ﬁbroblasts. In (D), the arrow
indicates a crista in a mitochondrion. The arrowhead indicates an area where the mitochondrial inner and outer membranes and the surrounding double membrane
of the autophagosome are clearly seen. Scale bars ¼ 200 nm. (F and G) Characteristic lysosomes in MLIV ﬁbroblasts containing concentric lamellar inclusions.
Scale bars ¼ 200 nm. (H) EM images of MLIV ﬁbroblasts showing autolysosomes containingthe concentric lamellar inclusionsand cytoplasmatic contents. Scale
bars ¼ 200 nm.
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(92% in control cells versus 68.8% in mutant cells after a
20 min recovery), demonstrating that fusion of autophago-
somes with late endosomes/lysosomes is less efﬁcient in
MCOLN1-deﬁcient cells.
Overexpression of MCOLN1 in NRK cells induces
accumulation of autophagosomes
It has been reported that the expression of certain proteins that
altertheendosomal/lysosomalpathwaymayaffecttheefﬁciency
of the autophagic process. For example, overexpression of a
mutant version of CHPM2B, one of the components of the
ESCRT-IIIcomplex,inducesaccumulationofLC3-positivevesi-
cles presumably due to defects in the fusion of autophagosomes
with MVBs (19). We have previously described that overexpres-
sion of MCOLN1 affects the endosomal/lysosomal pathway and
inducesenlargement oflateendosomes/lysomes (28).Therefore,
in this study, we examined whether MCOLN1 overexpression
might cause autophagosome accumulation.
To monitor autophagic activity, we followed changes in the
distribution of GFP-tagged LC3 transiently expressed in NRK
cells. Similar to endogenous LC3, GFP-LC3 was largely cyto-
solic in untreated NRK cells, and an obvious increase of punc-
tate vesicular structures labeled with GFP-LC3 was observed
after 3 h of starvation in EBSS (Fig. 7A). Interestingly, over-
expression of MCOLN1 caused a considerable accumulation
of GFP-LC3-labeled autophagosomes (Fig. 7B). Quantiﬁcation
of 300 cells per experimental condition showed that under nutri-
ent rich conditions, ,8% (7.21%, SD+0.58) of NRK cells
expressing GFP-LC3 alone displayed GFP-LC3 puncta. In con-
trast, 33% (SD+0.86) of cells co-expressing GFP-LC3 and
MCOLN1 showed GFP-LC3-positive vesicles (Fig. 7C).
Starvation-induced autophagy did not seem to be affected by
MCOLN1 expression, as the percentage of cells accumulating
GFP-LC3-labeled puncta after 3 h of incubation in EBSS
was very similar between cells expressing GFP-LC3 alone or
Figure 4. Starvation induces robust autophagy in ﬁbroblasts from MLIV patients. (A) Control ﬁbroblasts or MLIV ﬁbroblasts were ﬁxed under control conditions
(DMEM) or after 3 h of starvation and immunostained with an antibody to endogenous LC3. Note that, as shown in Figure 2, in normal conditions, LC3 shows a
vesicular staining in MLIV ﬁbroblasts in contrast with the diffuse staining in control ﬁbroblasts. After 3 hours of starvation autophagy is further increased. Scale
bar ¼ 10 mm. (B) Lysates from control ﬁbroblasts or ﬁbroblasts from a MLIV patient were collected from untreated cells (DMEM), cells starved for 3 hours in
the absence or presence of 50 mg/ml leupeptin, or cells starved for 3 hours followed by 1 hour of recovery (recovery). Endogenous LC3 (top) and actin (bottom)
were visualized by western blot. (C) Autophagy was measured as the ratio of LC3-II/LC3-I and is represented as a fold increase of the ratio from control cells in
normal media (DMEM). Results are means+S.D. (n ¼ 5). Starvationþleup P , 0.05; DMEM, Starvation P , 0.01; Recovery P , 0.001.
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SD+2.3, respectively) (Fig. 7C). Finally, the number of
GFP-LC3 positive vesicles decreased signiﬁcantly in both cell
types after 1 h recovery (Fig. 7C). Taken together, our results
indicate that alterations in the late endosomal/lysosomal
pathway induced by MCOLN1 overexpression result in abnor-
mal accumulation of autophagosomes in basal conditions.
Absence of MCOLN1 causes delayed transport of cargo
along the endosomal/lysosomal pathway
As mentioned above, fusion of autophagosomes with lyso-
somes is delayed in MLIV ﬁbroblasts, so we hypothesized
that fusion between late endosomes and lysosomes might
also be impaired in the absence of MCOLN1. To test this
possibility, we followed delivery of cargo from plasma mem-
brane to lysosomes. Platelet-derived growth factor receptor
(PDGFR) is a prototypical member of the receptor tyrosine
kinases family in which activation and trafﬁcking have been
exhaustively characterized (48). Ligand-induced dimerization
of the PDGF receptor leads to autophosphorylation of the
receptor and the subsequent binding and phosphorylation of
downstream signaling proteins. Termination of PDFGR sig-
naling occurs via endocytosis and delivery of the receptor to
lysosomes for degradation. We therefore stimulated cells
with PDGF for different periods of time and determined the
amount of PDGFR by immunoblot analysis. Interestingly,
Figure 5. Degradation of autophagosomes is delayed in MLIV ﬁbroblasts. (A) Control and MLIV ﬁbroblasts were starved in EBSS media for 3 h and then
allowed to recover for 20 or 40 min in complete medium. Cells were then ﬁxed and LC3 localization was examined by immunoﬂuorescence. Scale bar ¼
10 mm. (B) Percentage of cells showing more than 20, between 10 and 20 or less than 10 LC3-positive structures after a 20 min recovery (left panel) or
40 min of recovery (right panel).
2730 Human Molecular Genetics, 2008, Vol. 17, No. 17we observed that ligand-induced PDGFR degradation was
reduced in MCOLN1-deﬁcient cells when compared with
control cells (Fig. 8A). Quantitative analysis of three indepen-
dent experiments revealed that in MLIV ﬁbroblasts the
remaining amount of PDGFR at 60 and 90 min after ligand
stimulation was increased by more than 50% when compared
with control cells (Fig. 8B). These results indicate that
MCOLN1 is required for efﬁcient transport of PDGFR to lyso-
somes. These data combined are indicative that MCOLN1 is
required for the efﬁcient delivery of material from both late
endosomes and autophagosomes to lysosomes.
DISCUSSION
In this paper, we report constitutive activation of autophagy in
ﬁbroblasts obtained from MLIV patients. This activation was
observed under basal conditions and was the result of
increased autophagosome formation and delayed autophago-
some degradation. To monitor autophagy, we analyzed recruit-
ment of LC3 from the cytosol to vesicular structures, as well
as an increase in the levels of LC3-II. We found that the
number of LC3-positive puncta was dramatically increased
in MCOLN1-deﬁcient cells when compared with control ﬁbro-
Figure 6. Fusion of autophagosomes and lysosomes is delayed in MLIV ﬁbroblasts. (A) MLIV ﬁbroblasts were starved for 3 h and then allowed to recover 20 or
40 min in complete medium. Cells were ﬁxed, permeabilized and immunostained with a polyclonal antibody to LC3 (green) and a monoclonal antibody to CD63
(red). Insets are 3-fold magniﬁcation. Cells were examined by confocal ﬂuorescence microscopy. Merging images in the red and green channels generated the
third picture on each row; yellow indicates overlapping localization. Scale bar ¼ 10 mm. (B) Percentage of autophagosome–lysosome fusion events was quanti-
ﬁed both in control and MLIV ﬁbroblasts after 20 or 40 min of recovery, as the fraction of LC3 positive structures that co-localized with the lysosomal marker
CD63. 20 min recovery, P , 0.01; 40 min recovery, P , 0.05.
Human Molecular Genetics, 2008, Vol. 17, No. 17 2731Figure 7. Overexpression of MCOLN1 increases autophagy. (A) NRK cells were transfected with GFP-LC3 for 24 h. Untreated cells, cells starved in EBSS
media for 3 h (starvation, center) or starved for 3 h followed by 1 h of recovery in complete media (recovery, right), were ﬁxed and examined by confocal ﬂu-
orescence microscopy. Scale bar ¼ 10 mm. (B) NRK cells were co-transfected with GFP-LC3 and MCOLN1-FLAG, ﬁxed and stained with an antibody to
FLAG. Scale bar ¼ 10 mm. (C) Percentage of cells expressing GFP-LC3 in a vesicular pattern in normal conditions (untreated), after 3 h starvation or after
1 h of recovery, in the absence or presence of MCOLN1-FLAG. Results are means+SD (n ¼ 300), P , 0.001.
2732 Human Molecular Genetics, 2008, Vol. 17, No. 17blasts. Interestingly, most of the LC3-labeled structures also
contained p62, suggesting accumulation of ubiquitinated pro-
teins in MLIV ﬁbroblasts. Increased levels of LC3-II and
p62 were also conﬁrmed by immunoblot analysis. Treatment
with leupeptin and co-localization experiments between
CD63 and LC3 showed that fusion of autophagosomes with
late endosomes/lysosomes is not blocked in MLIV cells.
These data, together with the increased levels of beclin-1
observed in mutant ﬁbroblasts, suggest that autophagosome
accumulation must be at least partially due to increased
autophagosome formation. However, we also observed that
autophagosome maturation is less efﬁcient in MLIV patient
cells. Therefore, we suggest that both augmented autophago-
some formation and delayed autophagosome fusion with late
endosomes/lysosomes account for the autophagy induction
reported in MLIV cells.
MLIV is characterized by severe neurological abnormal-
ities; however, the underlying mechanism of neurodegenera-
tion is poorly understood. We propose that trafﬁcking
defects along the endosomal/lysosomal pathway due to the
absence of MCOLN1 impairs lysosomal function and results
in inefﬁcient autophagosome degradation. This in turn
causes accumulation of ubiquitinated aggregates that generate
cellular stress and further induces autophagosome formation
and accumulation (Fig. 9). Defects in autophagy may not be
especially detrimental in ﬁbroblasts, where the rapid division
of the cells helps to prevent the accumulation of misfolded
or aggregated proteins. However, the accumulation of these
products in neurons may result in cell death, and as the
neurons cannot be replaced, neurodegeneration occurs.
In addition, autophagic stress may cause accumulation
of damage organelles, such as mitochondria, making the
cells more susceptible to pro-apoptotic signals (49). In
support of this idea, a recent study described that MLIV
ﬁbroblasts accumulate fragmented mitochondria and exhibit
increased sensitivity to apoptosis induced by Ca
2þ-mobilizing
agonists (41).
Defects in autophagy caused by lysosomal malfunction may
not be an exclusive characteristic of MLIV. Recent evidence
shows that in many LSDs such as multiple sulfatase deﬁciency
and mucopolysaccharidosis type IIIA, accumulation of unde-
graded products in lysosomes impairs autophagosome matu-
ration, resulting in accumulation of ubiquitinated protein
aggregates and defective mitochondria (50). In addition,
factors which reduce lysosomal activity, for instance, aging
or oxidative stress, could reduce the ability of autophagy to
eliminate toxic or aggregated proteins thus exacerbating
age-related neurodegenerative disorders such as Parkinson’s,
Alzheimer’s and Huntington’s disease (5).
Accumulation of autophagosomes has also been described
in Niemann-Pick type C disease (NPC), a sphingolipid
storage disorder characterized by progressive neurodegenera-
tion (51). Interestingly, increased formation of autophago-
somes rather than defective degradation was observed in
Figure 8. Down-regulation of PDGFR is impaired in MLIV ﬁbroblasts. (A) Control ﬁbroblasts and MLIV ﬁbroblasts were starved for 16 h in DMEM containing
0.1% BSA and incubated with 100 ng/ml of PDGF-BB for the indicated times. Cells were then lysed, subjected to SDS–PAGE and immunoblotted with anti-
bodies against PDGFR. Lysates were also blotted for actin as a loading control. (B) Quantiﬁcation of the optical densities for the corresponding PDGFR bands
from three independent experiments.
Human Molecular Genetics, 2008, Vol. 17, No. 17 2733NPC. These results led to the suggestion that accumulation of
cholesterol in late endosomes/lysosomes increases the levels
of beclin-1 resulting in elevated basal autophagy (52). Abnor-
mal accumulation of cholesterol in late endosomes has also
been reported in MLIV ﬁbroblasts (36). Therefore, disrupted
cholesterol trafﬁcking could be the cause of the increased
autophagosome formation associated with elevated beclin-1
levels that we observe in MLIV cells, while defective lysoso-
mal function would account for the inefﬁcient autophagosome
degradation.
We cannot dismiss the possibility that MCOLN1 plays a
speciﬁc role in the fusion between autophagosomes and late
endosomes/lysosomes. Transient expression of MCOLN1 in
NRK cells induced accumulation of GFP-LC3-labeled ves-
icles. As it is improbable that many lipids accumulate within
lysosomes a short time after transfection, it is plausible that
the alteration of MCOLN1 function due to overexpression is
responsible for impaired autophagosome maturation. It has
also been suggested that MCOLN1 might regulate fusion/
ﬁssion events between late endosomes and lysosomes
(40,53). Consistent with this idea, we found that delivery of
PDGFR to lysosomes is delayed in MLIV ﬁbroblasts
(Fig. 8). In addition, it has recently been shown that transport
of ﬂuid-phased markers to lysosomes is slower in macro-
phages treated with MCOLN1 siRNA (54). Since some of
the proteins required for late endosome–lysosome fusion are
likely to be the same as those required for autophagosome–
lysosome fusion, it is possible that MCOLN1 participates in
both fusion events.
Our results suggest that modulation of autophagy might be
an effective strategy for treatment of MLIV. We found robust
induction of autophagy after starvation in both control and
MLIV cells, indicating that the autophagy machinery is
functional in MCOLN1-deﬁcient cells. Therefore, therapies
designed to induce autophagy activation, such as caloric
restriction or treatment with rapamycin, might help to over-
come the delayed autophagosome degradation seen in basal
conditions. This strategy has been suggested for the treatment
of other neurodegenerative disorders (55,56). For example,
autophagy induction by treatment with rapamycin has been
shown to attenuate neuronal death in animal models of Hun-
tington’s disease (57).
Figure 9. A proposed model of mechanism of defective autophagy induced neurodegeneration in MLIV patients. Trafﬁcking along the late endosomal/lysosomal
pathway is perturbed in MCOLN1-deﬁcient cells. As a result, fusion between autophagosomes and lysosomes is delayed and de novo formation of autophago-
somes is increased. Dysfunction of the autophagic pathway leads to accumulation of protein aggregates and to defects in organelle turnover thus rendering cells,
especially neurons, more susceptible to cell death.
2734 Human Molecular Genetics, 2008, Vol. 17, No. 17In summary, our data demonstrate the impact of lysosomal
function on autophagic activity and suggest that, analogous to
other LSDs, accumulation of ubiquitinated protein inclusions
due to defective autophagy may contribute to the neurodegen-
eration observed in MLIV patients.
MATERIALS AND METHODS
Antibodies and reagents
The primary antibodies used were: mouse monoclonal
anti-ubiquitin (FK2; MBL, Woburn, MA, USA), mouse
monoclonal anti-CD63 (H5C6) and mouse monoclonal
anti-p62 lck ligand (BD Pharmigen, San Jose, CA, USA),
mouse monoclonal anti-actin (BD Transduction, San Jose,
CA, USA), rabbit polyclonal anti-LC3 (Sigma, St Louis,
MO, USA), rabbit polyclonal anti-Beclin-1 (Cell Signaling
Technology, Beverly, MA, USA) and rabbit polyclonal
anti-PDGFR (Upstate/Millipore, Bellerica, MA, USA). The
secondary antibodies used were: goat anti-mouse or goat
anti-rabbit conjugated to Alexa Fluor 488 or 555 (Molecular
Probes, Eugene, OR, USA). HRP-conjugated anti-mouse
or anti-rabbit IgG (GE Healhcare/Amersham Bioscience,
Piscataway, NJ, USA). Leupeptin, mammalian protease
inhibitor cocktail and NP-40 were obtained from Sigma.
PDGF-BB was obtained from Upstate/Millipore.
Cell lines and transfections
Skin ﬁbroblasts from a MLIV patient (clone WG0909), the
corresponding heterozygous non-diseased parent skin ﬁbro-
blasts (clone WG0988) and unrelated non-diseased skin ﬁbro-
blasts (clone MCH065) were obtained from the Repository for
Mutant Human Cell Strains of Montreal Children’s Hospital
(Montreal, Canada). MLIV ﬁbroblast clone MG02527 was
from Coriell Cell Repositories (Boston, MA, USA). Fibro-
blasts and NRK cells were maintained in Dulbecco’s modiﬁed
Eagle’s medium (DMEM, Life technologies, Invitrogen/
Gibco, Carlsbad, CA, USA) supplemented with 100 U/ml
penicillin (Gibco) and 10% (w/v) fetal bovine serum (FBS).
Transfection of NRK cells was performed using FuGENE-6
(Roche Diagnostics, Indianapolis, IN, USA) according to the
manufacturer’s recommendations. Analyses were conducted
24 hours post-transfection.
Starvation of cells
Cells were starved by being washed three times with PBS
and incubated in EBSS (EBSS, Sigma) at 378Cf o r3h .T o
examine the recovery of cells from starvation, cells incubated
in EBSS for 3 h were transferred to DMEM–10% FBS at
378C for the indicated times.
Plasmids
GFP-LC3 chimera was a kind gift of Dale Hailey (NIH,
Bethesda, MD, USA). MCOLN1-FLAG was cloned as
described previously (35).
Immunoﬂuorescence microscopy
For immunoﬂuorescence, skin ﬁbroblasts or NRK cells were
grown on cover slips and ﬁxed in methanol/acetone (1:1, v/
v) for 10 min at 2208C. Incubation with primary antibodies
diluted in PBS, 0.1% (wt/vol) saponin and 0.1% BSA, was
carried out for 1 h at room temperature. Unbound antibodies
were removed by rinsing with PBS for 5 min, and cells were
subsequently incubated with a secondary antibody (Alexa555
or Alexa488-conjugated goat anti-rabbit or anti-mouse Ig)
diluted in PBS, 0.1% (wt/vol) saponin and 0.1% BSA,
for 30–60 min at room temperature. After a ﬁnal rinse
with PBS, cover slips were mounted onto glass slides with
Fluoromount G (Southern Biotechnology Associates, Bir-
mingham, AL, USA). Fluorescence images were acquired on
an LSM 510 confocal microscope (Carl Zeiss, Thornwood,
NY, USA). For co-localization analysis in recovery con-
ditions, six cells per cell line per experiment were imaged
and analyzed as follows: LC3 positive vesicles were counted
and marked by switching off the GFP channel. Then, the
GFP channel was switched back on and the number of
co-localized vesicles was counted. From these two values,
the fraction of co-localized vesicles was then determined.
Electron microscopy
Cells were cultured in 60 mm Permanox dishes (Nunc
Nalgene) and processed for transmission electron microscopy.
In brief, cultures were ﬁxed with glutaraldehyde and parafor-
maldehyde, post-ﬁxed with osmium tetroxide, stained en bloc
with uranyl acetate, ethanol dehydrated and Epon embedded.
Chemicals were from Electron Microscopy Sciences. Sections
60 nm thick were cut parallel to the adherent surface on a
Sorvall MT2 ultramicrotome, stained with uranyl acetate and
lead citrate and viewed with a JEM 1200 EXII electron micro-
scope (JEOL USA) equipped with an AMT XR-60 digital
camera (Advanced Microscopy Techniques).
Western blot
Fibroblasts were washed with ice-cold PBS, extracted in
ice-cold lysis buffer (25 mM Tris–HCl, pH 7.4, 150 mM
NaCl, 5 mM EDTA, 1% NP-40 supplemented with protease
inhibitor cocktails), centrifuged (16 000 g) for 10 min and
the supernatants (soluble fraction) were collected. To
analyze protein levels in the insoluble fractions, the remaining
protein pellets were washed with lysis buffer, centrifuged and
extracted with 2% SDS containing sample buffer. Samples
were analyzed by SDS–PAGE (4–20% gradient gels) under
reducing conditions and transferred on to nitrocellulose.
The membrane was then blocked with 1  PBS, 0.05%
Tween-20, 10% non-fat milk and incubated with the appro-
priate antibodies. Enhanced chemiluminescence reagent
(Amersham Biosciences) was used for protein detection. The
amounts of the different proteins were quantiﬁed by using
the public domain ImageJ program (1.38), normalized with
the actin content in the same sample and represented as fold
increase of the amount present in control ﬁbroblasts.
Human Molecular Genetics, 2008, Vol. 17, No. 17 2735Degradation of PDGFR
Skin ﬁbroblasts were serum starved for 16 h and stimulated
with PDGF-BB (100 ng/ml) for the indicated times. Total
cell lysates were subjected to immunoblotting with antibodies
against PDGFR. The amounts of PDGFR were quantiﬁed at
each time point by using the public domain ImageJ program
(1.38) and are represented as the percentage of remaining
PDGFR when compared with unstimulated ﬁbroblasts in the
same experiment.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG Online.
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